CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CLVSEUR | Clovis Oncology INC | Stock-Other | 45.41% | — | -50.00% | |
| 2 | FPRX | Five Prime Therapeutics INC | Stock-Other | 34.41% | — | — | |
| 3 | AKAOQ | Achaogen INC | Stock-Other | 9.80% | — | — | |
| 4 | ✓ | Biotie Therapies Oyj | Stock-Other | 6.81% | — | — | |
| 5 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 3.58% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | FPRX | Five Prime Therapeutics INC | +12.5% | — | Unchanged |
| 2 | AKAOQ | Achaogen INC | -1.2% | — | Unchanged |
| 3 | CBAYUSD | Cymabay Therapeutics INC | -2.8% | — | Unchanged |
| 4 | CLVSEUR | Clovis Oncology INC | -7.8% | -50.00% | Trim |
| 5 | ✓ | Biotie Therapies Oyj | — | NEW | New buy |
| 6 | INGN | Inogen INC | — | EXIT | Sold out |
| 7 | ✓ | Kythera Biopharmaceuticals I | — | EXIT | Sold out |